Did you miss one of our webinars? Simply select the appropriate link below and view the recorded webinar. It will not be interactive, but you will see the chat questions the original attendees asked. For additional information on the products discussed in the webinar, explore our links to videos and other resources.
If there is an area you would like to see covered, you can request a topic of your choice.
If you are experiencing issues opening the webinar recordings, please be sure that you have the latest Adobe Flash Player installed.
Monday, December 19, 2016
Mr. Jim Thomson
The PowerPlex® Y23 System is a 23-loci, 5-color Y-STR multiplex designed for genotyping forensic casework samples, database samples and paternity samples.
In this webinar, Jim Thomson from LGC Group described the use of PowerPlex® Y23 System on difficult sexual offense cases, particularly those in which no sperm was identified. He shared success rates on different categories derived from a case study carried out on samples provided by nominated participating UK police forces.
Tuesday, December 06, 2016
Leta Steffen, PhD
Don't settle for a mediocre PCR assay. Learn how experts develop robust and reliably performing PCR assays.
Tuesday, November 08, 2016
Betsy Herold, MD
Antibody dependent cell mediated cytotoxicity (ADCC) is an important immune effector mechanism against tumor and virus-infected cells. In recent years, ADCC has emerged as an important protective immune correlate in a number of vaccine studies for HIV and influenza. This webinar will highlight recent studies demonstrating the central role of FcR functions in vaccine-mediated protection against HSV-1 and HSV-2 infection, challenging the existing paradigm that high titer neutralizing antibodies are required.
Tuesday, October 25, 2016
Micheal M. Rosenblatt, PhD
Traditional protocols require digestion times of up to 18 hours, as well as reduction and alkylation prior to digestion. These denaturants often inhibit enzymes and modify proteins, and require removal prior to analysis. What if you could shorten digestion times to ~30 minutes, without denaturants or reductants or alkylating agents?
Tuesday, September 27, 2016
Richard Somberg, PhD
Therapeutic antibodies designed to block or activate immune checkpoint receptors are a powerful new approach to the treatment of cancer and other diseases. However, due to their biologic complexity the development of therapeutic antibodies requires unique functional and analytical tools. Here we present a suite of MOA-based functional bioassays for use in antibody screening, characterization, potency testing and stability studies.